🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to establish proof of efficacy for namilumab i...
Status
Completed
Location
Multiple Locations
Start Date
2014-06
Trial ID
NCT02129777
The purpose of this study is to obtain blood samples from up to 14 particip...
Status
Completed
Location
Multiple Locations
Start Date
2015-11-19
Trial ID
NCT02528786
Treatments Being Tested
The study will assess the effect of namilumab, a GM-CSF inhibitor, on the c...
Status
Completed
Location
Royal United Hospitals Bath
Start Date
2018-09-06
Trial ID
NCT03622658
The purpose of this trial is primarily to investigate the safety and tolera...
Status
Completed
Location
Nycomed Investigational Site
Start Date
2011-03
Trial ID
NCT01317797
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of namilum...
Status
Terminated
Location
Multiple Locations
Start Date
2015-04-08
Trial ID
NCT02393378
Treatments Being Tested
The purpose of this study is to establish proof of concept and identify the...
Status
Completed
Location
Multiple Locations
Start Date
2014-12-17
Trial ID
NCT02379091
Treatments Being Tested
The purpose of this study is to evaluate safety, pharmacokinetics and pharm...
Status
Completed
Location
Multiple Locations
Start Date
2014-11
Trial ID
NCT02354599
A Randomized, Double-blind, Placebo-controlled, Study with an Open-label Co...
Status
Terminated
Location
Kinevant Study Site
Start Date
2022-08-23
Trial ID
NCT05351554
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled study with an open-l...
Status
Terminated
Location
Kinevant Study Site
Start Date
2022-08-31
Trial ID
NCT05314517